Letermovir - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Phenylpiperazine owl:NamedIndividual Fluoroarene Orphan drug Trifluoromethyl compound Anti-herpes virus drug Carboxylic acid Merck & Co. brand Drug granted breakthrough therapy designation
rdfs:label	Letermovir
owl:sameAs	dbr:Letermovir
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Trifluoromethyl_compounds http://en.wikipedia.org/wiki/List_of_antiviral_drugs http://en.wikipedia.org/wiki/Category:Phenylpiperazines http://en.wikipedia.org/wiki/Category:Anti-herpes_virus_drugs http://en.wikipedia.org/wiki/Category:Fluoroarenes http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Carboxylic_acids http://en.wikipedia.org/wiki/Category:Merck_&_Co._brands http://en.wikipedia.org/wiki/List_of_carboxylic_acids
skos:prefLabel	Letermovir
skos:altLabel	letermovir
clgo:alternativeName	Prevymis
clgo:bioavailability	37.0
clgo:casNumber	917389-32-3
clgo:chEMBL	1241951
clgo:drugbank	DB12070
clgo:fdaUniiCode	1H09Y5WO1F
clgo:kegg	D10801
clgo:medlinePlus	a618006
clgo:pubchem	45138674

About: clgr:Letermovir